Navigation Links
Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management

A Complimentary Continuing Education Virtual Lecture for Healthcare Professionals

VOORHEES, N.J., Jan. 19 /PRNewswire/ -- Clostridium difficile infection (CDI) is increasingly being seen in older adults, especially among residents of long-term care facilities (LTCFs). This is further complicated by the emergence of a virulent strain of C. difficile associated with high rates of morbidity and mortality.

Implementing strategies for prevention and control, early diagnosis and prompt aggressive treatment is critical in managing CDI.

To address the need for current education on CDI, especially among healthcare professionals working in LTCFs, Robert Michael Educational Institute LLC (RMEI) and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education Medscape virtual lecture entitled, "Clostridium difficile Infection in Long-Term Care: Tailored Approaches to Management." This virtual lecture offers continuing education credit for physicians, pharmacists and registered nurses and is supported by an educational grant from ViroPharma Incorporated.

Donald Kaye, MD, MACP, Professor of Medicine at Drexel University College of Medicine in Philadelphia, Pennsylvania, and Kurt B. Stevenson, MD, MPH, Associate Professor in Internal Medicine and Associate Director of Clinical Epidemiology at Ohio State University College of Medicine in Columbus, Ohio will serve as faculty for this activity.

Healthcare professionals can access the virtual lecture at

Healthcare professionals working in LTCFs should take advantage of this opportunity to learn important insights and guidelines for managing this rapidly changing disease.

"Robert Michael Educational Institute LLC recognizes that continuing education plays a crucial role in the provision of quality health care and is dedicated to offering professionals meaningful opportunities for lifelong learning," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and non-accredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit

SOURCE Robert Michael Educational Institute LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Cepheid Launches First On-Demand Molecular Diagnostic Test for Clostridium Difficile Into European Market
2. Current Concepts in Clostridium difficile Infection: A Focus on Geriatric and Pediatric Patients
3. BD Announces FDA 510(k) Clearance of Novel Molecular Assay to Diagnose Clostridium difficile Infections
4. National Experts Team Up to Help Hospitals Prevent and Control C. difficile Outbreaks
5. APIC launches first national C. difficile prevalence study
6. APIC Launches First National C. Difficile Prevalence Study
7. Advances in C. difficile research
8. New Report Shows High C-difficile Infection Rates in U.S. Hospitals
9. MRSA and C. difficile Infections Reduced by 50% in Hospital Study
10. HPV vaccine does not appear to be effective for treating pre-existing HPV infection
11. Mayo Clinic researchers discover new diagnostic test for detecting infection in prosthetic joints
Post Your Comments:
(Date:11/28/2015)... Aliso Viejo, CA (PRWEB) , ... November 28, 2015 , ... ... 30 new fully customizable media panels to choose from, the possibilities are endless. Users ... angle, and more. With the ProPanel: Pulse masking effects, users are sure to get ...
(Date:11/27/2015)... (PRWEB) , ... November 27, 2015 , ... According to ... out by the University of Toronto and the University of British Columbia suggested that ... for head injuries. The article explains that part of the reason for the controversial ...
(Date:11/27/2015)... ... 27, 2015 , ... A team of Swiss doctors has released a report ... has just posted the findings on the website. Click here to read the ... 136 mesothelioma patients who were treated with chemotherapy followed by EPP surgery. Among the ...
(Date:11/27/2015)... ... 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that will ... their purchase of lice treatment product. In addition, customers will receive a complimentary head ... “Finding lice is a sure way to ruin the holidays, so we encourage all ...
(Date:11/27/2015)... CA (PRWEB) , ... November 27, 2015 , ... MPWH, the No.1 Herpes-only dating community ... 30 (see Table 1-1 ). More than 3.7 billion people under the age ... type 1 (HSV-1), according to WHO's first global estimates of HSV-1 infection . , ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... 2015  The American Academy of Pediatrics (AAP), ... the March of Dimes cheered today,s signature into ... Act of 2015 (S.799), which takes much-needed ... exposed to drugs, such as opioids, and to ... three organizations have worked together leading advocacy efforts ...
(Date:11/25/2015)... 2015 On Tuesday, November 24, 2015, ... against Wright Medical Technology, Inc. for product liability ... hip implant device, awarded $11 million in favor ... trial and three days of deliberations, the jury ... defectively designed and unreasonably dangerous, and that Wright ...
(Date:11/25/2015)... Israel , November 25, 2015 ... KTOV ) (TASE: KTOV), a biopharmaceutical company focused ... treatment of various clinical conditions, today announced the closing ... American Depository Shares ( ADSs ), each representing 20 ... up to 3,158,900 ADSs. The ADSs and warrants were ...
Breaking Medicine Technology: